肾小管间质毒性肾病:核心教程2024
本文综述毒性肾病中肾小管间质损伤的机制与临床管理。毒性肾病由内源性或外源性毒素引起,可累及肾小球、血管或肾小管间质;肾小管间质损伤常表现为肾功能下降和/或溶质转运缺陷及溶质流失。损伤在有限暴露下常可逆,但 prolonged 暴露可致不可逆损伤。
要点
- 内源性与外源性毒素均可致肾小管间质损伤,肾功能下降和溶质流失是常见表现。
- 毒素结构、剂量、代谢途径及患者遗传与共病因素共同决定肾毒性风险。
- 有限暴露所致损伤常可逆,但 prolonged 暴露可致不可逆肾损伤。
核心结论
- 毒性肾病是临床常见的一组毒素所致肾损伤,可影响肾小球、血管或肾小管间质。
- 肾小管间质损伤常表现为肾功能下降和/或溶质转运缺陷及溶质流失,有限暴露下常可逆, prolonged 暴露可致不可逆损伤。
主要发现
- 内源性毒素包括肌红蛋白、血红蛋白、单克隆轻链和溶菌酶等;外源性毒素包括治疗药物、草药、重金属、放射造影剂、毒物和环境暴露等。
- 肾脏通过肾小球滤过和肾小管分泌代谢与排泄物质,增加其对毒素不良效应的易感性。
- 药物/毒素的结构、剂量、代谢处理和经肾排泄途径决定其肾毒性风险。
- 影响风险的患者特征包括药物代谢、转运和排泄的遗传决定因素、免疫应答基因及共病状况。
临床怎么用
- 临床应识别内源性与外源性肾毒性毒素,并评估患者遗传与共病相关风险。
- 肾小管间质损伤常以肾功能下降和/或溶质转运缺陷及溶质流失为表现,需监测相应指标。
- 有限毒素暴露所致损伤常可逆,应尽早识别并限制暴露以防不可逆损伤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Toxic nephropathies are a clinically common group of disorders characterized by toxin-induced renal injury that can affect the glomerulus, vasculature, or tubulointerstitium. Various endogenous (eg, myoglobin, hemoglobin, monoclonal light chains, and lysozymes) and exogenous toxins (eg, therapeutic drugs, herbal medications, heavy metals, radiocontrast, intoxicants, and environmental exposures) have been implicated. The kidney's primary role of metabolism and excretion of substances via glomerular filtration and tubular secretion increases its susceptibility to their adverse effects. The structure, dose, metabolic handling, and excretory pathway of the drug/toxin through the kidney determines its nephrotoxic risk. Patient characteristics that impact risk include genetic determinants of drug metabolism, transport and excretion, immune response genes, and comorbid conditions. Clinical manifestations depend on site and severity of renal injury. Toxin-induced tubulointerstitial injury often presents as a decline in renal function and/or solute transport defects and renal solute wasting. Injury is often reversible with limited toxin exposure; however, irreversible renal injury can occur with prolonged exposure. In this Core Curriculum, we will focus on discussing mechanisms of common toxin-induced tubulointerstitial renal injury and review their causes, clinical presentations, diagnosis, and management.
引用
- Krishnan N, Moledina DG, Perazella MA, et al. Toxic Nephropathies of the Tubulointerstitium: Core Curriculum 2024. Am J Kidney Dis. 2024. PMID: 38243994. doi:10.1053/j.ajkd.2023.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。